| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash used in investing activities | -138 | -128 |
| Cash paid for employee withholding taxes related to the vesting of restricted stock units | 188 | - |
| Proceeds from exercise of stock options | 338 | - |
| Repayment of long-term debt | 5,500 | 5,000 |
| Cash paid for employee withholding taxes related to the vesting of restricted stock units | - | 92 |
| Net cash used in financing activities | -5,350 | -5,092 |
| Net increase in cash and cash equivalents | 6,139 | 3,205 |
| Cash and cash equivalents at beginning of period | 13,380 | - |
| Cash and cash equivalents at end of period | 19,519 | - |
OptimizeRx Corp (OPRX)
OptimizeRx Corp (OPRX)